Resources Case Studies Coding & Billing Implementation Tools Package Inserts Product Information Videos, Webinars, & Podcasts Select ProductPlateletsAll ProductsIFCPlasmaPlateletsPRPCRSelect Resource TypeAll Resource TypesCase StudiesCoding & BillingImplementation ToolsPackage InsertsProduct InformationVideos, Webinars, & PodcastsUINTERCEPT Goes Beyond – Platelets and IFCINTERCEPT Blood System for PlateletsINTERCEPT Blood System Mechanism of ActionAssessing Platelet Availability – PR vs. LVDSUse of PR Platelets for Patient Safety and SustainabilityOptimizing Platelet Availability and Access to 100% PR InventoryUS Tertiary Care Hospital Gains Operational Efficiency and Fresher PlateletsVersiti PR Scale-UpImplementation of PR at Puerto Rico Blood Center During Zika OutbreakStanford Blood Center Implements 100% PRPlatelets and Plasma Outpatient Information GuideISBT Platelets CodesBest Practices Platelet Handling Guide – HospitalsPR Platelets Implementation GuideNurse Handout TemplateSample Labels SheetSample SBAR SheetSample Tie Tags SheetNurse Training ModuleImplementing INTERCEPT Platelets – E-learning TestPlatelets Small Volume (SV) – INT2130BPlatelets Large Volume (LV) – INT2230BPlatelets Dual Storage (DS) – INT2530BPlatelets Dual Storage (DS) Semi-Integrated Set – INT2540BPlatelets Small Volume (SV) Semi-Integrated Set – INT2140BPlatelets Large Volume (LV) Semi-Integrated Set – INT2240BCMV Mitigation SheetINTERCEPT Platelets Interview: Dr. Maria De Los Angeles Muñiz – Robert Wood Johnson University HospitalINTERCEPT Plasma Specifications InsertPlatelets Safety and Efficacy Technical SheetINTERCEPT Semi-integrated Sets Specifications InsertINTERCEPT Integrated Sets Specifications InsertPR – Proactive Strategy for Blood Safety in Pandemic PreparationINTERCEPT Platelets Interview: Dr. Shannon Walker – Vanderbilt University Medical CenterMethodologies for Reducing the Risk of TA-GVHD from Platelet TransfusionsINTERCEPT Platelets Interview: Dr. Deva Sharma – Vanderbilt University Medical CenterComparing Useable Shelf-life of PR Platelets vs LVDS Screened Platelets – OneBloodImpact of PR vs LVDS Testing on Platelet AvailabilityThe Effects of PAS and PR on Platelet Use – Roswell Park Cancer InstituteLogistical Management of Incorporating Pathogen Reduced Platelets into Inventory – Yale New-Haven HospitalPhased Implementation of Pathogen-Reduced Platelets – UCSDPlatelets Economic Model – RutgersSafety and Efficacy of Amotosalen-UVA PR Platelet Components Transfused to Mature and Premature Neonates – Cerus CorporationImpact of Amotosalen/UVA Process for PR in PLT Concentrates on Transfusion Efficiency in Cardiac Surgery – Saint-Etienne, France2023 AABB Abstract BookINTERCEPT Platelets Publications ListSeptic Transfusion Reaction Awareness2022 AABB Abstract BookPathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT® Fibrinogen Complex or IFC) and INTERCEPT® treated Platelets: Expanding the Use of Pathogen Reduction for Improved Blood SafetyLocal transmission of dengue virus – considerations for blood safety and the role of PRImplementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Johns Hopkins All Children’s Hospital)Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Allegheny Health Network)Impact of Anaerobic Culture of Platelets on Safety and OperationsPathogen Reduction of Platelets: Patient Safety and FDA Platelet Bacterial Guidance CompliancePathogen Reduction of Platelets: Guidance Compliance and ImplementationPreparing Our Blood Supply for the Next Pandemic with Dr. Susan StramerUpdating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet TechnologiesImplementing Pathogen Reduced (PR) INTERCEPT Platelets and Pediatric ConsiderationsPathogen Reduced Platelet Implementation at Stanford HospitalPlatelet Component Bacterial Risk Control: An Evolution in ProgressPlatelet Pathogen Reduction Technology Implementation at Stanford Blood CenterThe Rationale for Pathogen Reduction: Blood Center and Transfusion Services PerspectivesMerits and Pitfalls of Automated Bacterial Culture Methods in Improving Bacterial Safety of Platelet ConcentratesImpact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER StudyHemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary BypassReview of Neonate to Pediatric Patient Outcomes Transfused with Amotosalen/UVA Treated PlateletsAssessing Platelet Availability from Blood Center and Hospital PerspectivesEvaluating Usable Shelf-Life of Pathogen Reduced and LVDS Tested Platelet ComponentsINTERCEPT Mechanism of Action Video Animation
INTERCEPT Platelets Interview: Dr. Maria De Los Angeles Muñiz – Robert Wood Johnson University Hospital
Logistical Management of Incorporating Pathogen Reduced Platelets into Inventory – Yale New-Haven Hospital
Safety and Efficacy of Amotosalen-UVA PR Platelet Components Transfused to Mature and Premature Neonates – Cerus Corporation
Impact of Amotosalen/UVA Process for PR in PLT Concentrates on Transfusion Efficiency in Cardiac Surgery – Saint-Etienne, France
Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT® Fibrinogen Complex or IFC) and INTERCEPT® treated Platelets: Expanding the Use of Pathogen Reduction for Improved Blood Safety
Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Johns Hopkins All Children’s Hospital)
Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Allegheny Health Network)
Updating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet Technologies
Merits and Pitfalls of Automated Bacterial Culture Methods in Improving Bacterial Safety of Platelet Concentrates
Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study